Table 4.
Parameters | Control male | Treated male | Control female | Treated female |
---|---|---|---|---|
SGPT (IU/L) | 78.4 ± 5.6 | 69.50 ± 7.19 | 80.8 ± 7.3 | 78.97 ± 6.7 |
SGOT (IU/L) | 154.04 ± 8.75 | 138.73 ± 9.44 | 141 ± 7.6 | 137.37 ± 8.34 |
ALP (IU/L) | 151 ± 6.36 | 144.75 ± 5.41 | 153.3 ± 8.57 | 164.52 ± 9.19 |
BIT (mg/dl) | 0.09 ± 0.01 | 0.11 ± 0.01 | 0.12 ± 0.03 | 0.11 ± 0.02 |
UREA (mg/dl) | 55.3 ± 1.85 | 61.10 ± 2.24 | 53.8 ± 2.2 | 50.37 ± 2.12 |
CRE (mg/dl) | 0.81 ± 0.01 | 0.78 ± 0.01 | 0.72 ± 0.02 | 0.69.57 ± 0.1 |
UA (mg/dl) | 2.55 ± 0.1 | 2.11 ± 0.12 | 2.58 ± 0.16 | 2.36 ± 0.21 |
TRIG (mg/dl) | 70.2 ± 4.87 | 67.75 ± 5.94 | 83.1 ± 5.34 | 74.54 ± 4.31 |
CHO (mg/dl) | 57.6 ± 5.67 | 61.25 ± 3.69 | 63.8 ± 3.8 | 55.19 ± 5.53 |
GLU (mg/dl) | 83.3 ± 5.99 | 73.70 ± 4.57 | 79.4 ± 5.6 | 77.38 ± 5.78 |
ALB (g/dl) | 4.2 ± 0.14 | 4.08 ± 0.21 | 4.56 ± 0.11 | 4.34 ± 0.17 |
PRO (g/dl) | 7.51 ± 0.22 | 7.76 ± 0.33 | 7.26 ± 0.12 | 7.13 ± 0.24 |
HDLC (mg/dl) | 31.92 ± 3.22 | 33.53 ± 3.17 | 34.73 ± 3.57 | 35.76 ± 3.94 |
The values are expressed as mean ± SEM. n = 5 in each group.
p < 0.05 as compared with controls (one-way ANOVA).